AYTU BIOPHARMA CEO Joshua Disbrow's 2019 pay jumps 72% to $1M
AYTU BIOPHARMA reports 2019 executive compensation
By ExecPay News
Published: April 16, 2021
AYTU BIOPHARMA reported fiscal year 2019 executive compensation information on April 16, 2021.
In 2019, four executives at AYTU BIOPHARMA received on average a compensation package of $802K, a 142% increase compared to previous year.
Average pay of disclosed executives at AYTU BIOPHARMA
Joshua R. Disbrow, Chief Executive Officer, received $1M in total, which increased by 72% compared to 2018. 55% of Disbrow's compensation, or $579K, was in stock awards. Disbrow also received $135K in bonus and $330K in salary.
Jarrett T. Disbrow, Chief Operating Officer, received a compensation package of $793K, which increased by 76% compared to previous year. 55% of the compensation package, or $438K, was in stock awards.
since December David A. Green, Chief Financial Officer, earned $686K in 2019.
David A. Green, Chief Financial Officer, received $686K in 2019, which increases by 139% compared to 2018.
AYTU BIOPHARMA's fiscal year ends on June 30.
Related executives
You may also like
Source: SEC filing on April 16, 2021.